Amber Podoll, Richard Furie, Francis Kim, Justin Chou, Ranjita Sengupta, Ruthee Bayer, Jonathan Gutman, James Chung
{"title":"P95 首批接受抗 CD19 嵌合抗原受体 (CAR) T 细胞疗法治疗的两名狼疮性肾炎 (LN) 美国患者:KYV-101 的 KYSA-1 多中心 1 期研究的初步结果","authors":"Amber Podoll, Richard Furie, Francis Kim, Justin Chou, Ranjita Sengupta, Ruthee Bayer, Jonathan Gutman, James Chung","doi":"10.1136/lupus-2024-el.149","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":20386,"journal":{"name":"Poster presentations","volume":"165 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"P95 First two US patients with lupus nephritis (LN) treated with anti-CD19 chimeric antigen receptor (CAR) T-cell therapy: preliminary results from the KYSA-1 phase 1, multicenter study of KYV-101\",\"authors\":\"Amber Podoll, Richard Furie, Francis Kim, Justin Chou, Ranjita Sengupta, Ruthee Bayer, Jonathan Gutman, James Chung\",\"doi\":\"10.1136/lupus-2024-el.149\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":20386,\"journal\":{\"name\":\"Poster presentations\",\"volume\":\"165 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Poster presentations\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/lupus-2024-el.149\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Poster presentations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/lupus-2024-el.149","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
P95 First two US patients with lupus nephritis (LN) treated with anti-CD19 chimeric antigen receptor (CAR) T-cell therapy: preliminary results from the KYSA-1 phase 1, multicenter study of KYV-101